Pleiotropic vascular protective effects of statins in perioperative medicine

Acta Anaesthesiologica Taiwanica

Volumn 51, Issue 3, 2013, Pages 120-126

  Fang, Shin Yuan ^a   Roan, Jun Neng ^a   Luo, Chwan Yau ^a   Tsai, Yu Chuan ^a,b   Lam, Chen Fuh ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

endothelium; hydroxymethylglutaryl CoA reductase inhibitors; mevalonic acid: mevalonate; nitric oxide; terpenes: isoprenoids

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVALONIC ACID; MEVINOLIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; SUXAMETHONIUM;

ABDOMINAL AORTA ANEURYSM; CARDIOVASCULAR FUNCTION; DRUG ANTAGONISM; DRUG INTOXICATION; ENDOTHELIAL DYSFUNCTION; GENERAL ANESTHESIA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART SURGERY; HUMAN; LIVER TOXICITY; MUSCLE TOXICITY; MYOPATHY; PERIOPERATIVE PERIOD; PLEIOTROPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHABDOMYOLYSIS; SIDE EFFECT; TREATMENT OUTCOME; VASCULAR SURGERY;

ENDOTHELIUM; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEVALONIC ACID: MEVALONATE; NITRIC OXIDE; TERPENES: ISOPRENOIDS;

ANESTHESIA, GENERAL; BLOOD VESSELS; CARDIOVASCULAR SURGICAL PROCEDURES; CHOLESTEROL, LDL; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MEVALONIC ACID; VASCULAR SURGICAL PROCEDURES;

EID: 84886443435     PISSN: 18754597     EISSN: 1875452X     Source Type: Journal    
DOI: 10.1016/j.aat.2013.08.003     Document Type: Review

References (59)

1. D.W. Russell Cholesterol biosynthesis and metabolism Cardiovasc Drugs Ther 6 1992 103 110
2. M.H. Moghadasian Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Life Sci 65 1999 1329 1337 (Pubitemid 29425973)
3. S. Bellosta, R. Paoletti, and A. Corsini Safety of statins: focus on clinical pharmacokinetics and drug interactions Circulation 109 23 suppl 1 2004 III50 III57
4. J.E. Edwards, and R.A. Moore Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials BMC Fam Pract 4 2003 18
5. J.C. LaRosa, J. He, and S. Vupputuri Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials JAMA 282 1999 2340 2346 (Pubitemid 30013066)
6. M. Endres, U. Laufs, Z. Huang, T. Nakamura, P. Huang, and M.A. Moskowitz Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase Proc Natl Acad Sci USA 95 1998 8880 8885 (Pubitemid 28350583)
7. L. Kalinowski, L.W. Dobrucki, V. Brovkovych, and T. Malinski Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin Circulation 105 2002 933 938 (Pubitemid 34184570)
8. M. Eto, T. Kozai, F. Cosentino, H. Joch, and T.F. Lüscher Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways Circulation 105 2002 1756 1759 (Pubitemid 34408880)
9. J. Wang, T. Tokoro, K. Matsui, S. Higa, and I. Kitajima Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells Life Sci 76 2005 2257 2268 (Pubitemid 40283650)
10. U. Laufs, and J.K. Liao Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase J Biol Chem 273 1998 24266 24271 (Pubitemid 28435775)
11. J.L. Mehta, J. Chen, P.L. Hermonat, F. Romeo, and G. Novelli Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders Cardiovasc Res 69 2006 36 45 (Pubitemid 41814809)
12. T. Sawamura, N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, and Y. Aiba An endothelial receptor for oxidized low-density lipoprotein Nature 386 1997 73 77 (Pubitemid 27130922)
13. E. Chavakis, E. Dernbach, C. Hermann, U.F. Mondorf, A.M. Zeiher, and S. Dimmeler Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway Circulation 103 2001 2102 2107 (Pubitemid 32373015)
14. A. Blair, P.W. Shaul, I.S. Yuhanna, P.A. Conrad, and E.J. Smart Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation J Biol Chem 274 1999 32512 32519
15. D.W. Stepp, J. Ou, A.W. Ackerman, S. Welak, D. Klick, and K.A. Pritchard Jr. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ Am J Physiol Heart Circ Physiol 283 2002 H750 H759
16. R.A. Catar, G. Müller, J. Heidler, G. Schmitz, S.R. Bornstein, and H. Morawietz Low-density lipoproteins induce the renin-angiotensin system and their receptors in human endothelial cells Horm Metab Res 39 2007 801 805 (Pubitemid 350206901)
17. J. Chen, D. Li, R. Schaefer, and J.L. Mehta Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan Atherosclerosis 184 2006 295 301 (Pubitemid 43049713)
18. C.M. Boulanger, F.C. Tanner, M.L. Béa, A.W. Hahn, A. Werner, and T.F. Lüscher Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium Circ Res 70 1992 1191 1197
19. M.E. Ivey, N. Osman, and P.J. Little Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis Atherosclerosis 199 2008 237 247
20. L. Kalinowski, I.T. Dobrucki, and T. Malinski Cerivastatin potentiates nitric oxide release and enos expression through inhibition of isoprenoids synthesis J Physiol Pharmacol 53 2002 585 595 (Pubitemid 36014804)
21. F. Jantzen, S. Könemann, B. Wolff, S. Barth, A. Staudt, and H.K. Kroemer Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells J Physiol Pharmacol 58 2007 503 514 (Pubitemid 47523093)
22. A.H. Wagner, T. Köhler, U. Rückschloss, I. Just, and M. Hecker Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation Arterioscler Thromb Vasc Biol 20 2000 61 69 (Pubitemid 30048347)
23. C. Vecchione, M.T. Gentile, A. Aretini, G. Marino, R. Poulet, and A. Maffei A novel mechanism of action for statins against diabetes-induced oxidative stress Diabetologia 50 2007 874 880 (Pubitemid 46355833)
24. H. Nishimatsu, E. Suzuki, H. Satonaka, R. Takeda, M. Omata, and T. Fujita Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats Am J Physiol Heart Circ Physiol 288 2005 H1770 H1776
25. O. Hofnagel, B. Luechtenborg, H. Eschert, G. Weissen-Plenz, N.J. Severs, and H. Robenek Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins Arterioscler Thromb Vasc Biol 26 2006 604 610
26. T. Matsumoto, M. Fujita, T. Sawamura, A. Kakino, Y. Sato, and Y. Fujita Pitavastatin reduces lectin-like oxidized low-density lipoprotein receptor-1 ligands in hypercholesterolemic humans Lipids 45 2010 329 335
27. Y. Rikitake, S. Kawashima, S. Takeshita, T. Yamashita, H. Azumi, and M. Yasuhara Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits Atherosclerosis 154 2001 87 96 (Pubitemid 32008567)
28. J.A. Beckman, J.K. Liao, S. Hurley, L.A. Garrett, D. Chui, and D. Mitra Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein Circ Res 95 2004 217 223 (Pubitemid 38988689)
29. M. Sugiyama, M. Ohashi, H. Takase, K. Sato, R. Ueda, and Y. Dohi Effects of atorvastatin on inflammation and oxidative stress Heart Vessels 20 2005 133 136 (Pubitemid 41031009)
30. J.N. Roan, S.Y. Fang, S.W. Chang, C.H. Hsu, C.C. Huang, and M.H. Chiou Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model J Vasc Surg 56 2012 1381 1389 e1
31. S.Y. Fang, J.N. Roan, Y. Lin, C.H. Hsu, S.W. Chang, and C.C. Huang Rosuvastatin suppresses oxidative response in the venous limb of arteriovenous fistula and enhances fistula blood flow in diabetic rats J Vasc Res 2013 in press
32. F. Mraiche, J. Cena, D. Das, and B. Vollrath Effects of statins on vascular function of endothelin-1 Br J Pharmacol 144 2005 715 726 (Pubitemid 40445620)
33. S. Dimmeler, A. Aicher, M. Vasa, C. Mildner-Rihm, K. Adler, and M. Tiemann HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway J Clin Invest 108 2001 391 397 (Pubitemid 32730785)
34. Y. Liu, J. Wei, S. Hu, and L. Hu Beneficial effects of statins on endothelial progenitor cells Am J Med Sci 344 2012 220 226
35. Q. Zhou, and J.K. Liao Pleiotropic effects of statins. Basic research and clinical perspectives Circ J 74 2010 818 826
36. P. Balakumar, S. Kathuria, G. Taneja, S. Kalra, and N. Mahadevan Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins? J Mol Cell Cardiol 52 2012 83 92
37. J.T. Christenson Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG Eur J Cardiothorac Surg 15 1999 394 399
38. E.W. Kuhn, O.J. Liakopoulos, S. Stange, A.C. Deppe, I. Slottosch, and Y.H. Choi Preoperative statin therapy in cardiac surgery: a meta-analysis of 90 000 patients Eur J Cardiothorac Surg 2013 in press [Epub ahead of print (PMID 23562936)]
39. L.M. Fedoruk, H. Wang, M.R. Conaway, I.L. Kron, and K.C. Johnston Statin therapy improves outcomes after valvular heart surgery Ann Thorac Surg 85 2008 1521 1526 (Pubitemid 351608190)
40. E.W. Kuhn, O.J. Liakopoulos, Y.H. Choi, and T. Wahlers Current evidence for perioperative statins in cardiac surgery Ann Thorac Surg 92 2011 372 379
41. D. Poldermans, J.J. Bax, M.D. Kertai, B. Krenning, C.M. Westerhout, and A.F. Schinkel Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery Circulation 107 2003 1848 1851 (Pubitemid 36444123)
42. M.D. Kertai, E. Boersma, C.M. Westerhout, J. Klein, H. van Urk, and J.J. Bax A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery Eur J Vasc Endovasc Surg 28 2004 343 352 (Pubitemid 39207082)
43. J. Kennedy, H. Quan, A.M. Buchan, W.A. Ghali, and T.E. Feasby Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients Stroke 36 2005 2072 2076 (Pubitemid 41429222)
44. O. Schouten, E. Boersma, S.E. Hoeks, R. Benner, H. van Urk, and M.R. van Sambeek Fluvastatin and perioperative events in patients undergoing vascular surgery N Engl J Med 36 2009 980 989
45. V. Chopra, D.H. Wesorick, J.B. Sussman, T. Greene, M. Rogers, and J.B. Froehlich Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis Arch Surg 147 2012 181 189
46. G.C. Fonarow, R.S. Wright, F.A. Spencer, P.D. Fredrick, W. Dong, and N. Every Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality Am J Cardiol 96 2005 611 616 (Pubitemid 41207298)
47. Y. Le Manach, G. Godet, P. Coriat, C. Martinon, M. Bertrand, and M.H. Fléron The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery Anesth Analg 104 2007 1326 1333 (Pubitemid 46795280)
48. L.A. Fleisher, J.A. Beckman, K.A. Brown, H. Calkens, E.L. Chaikof, and K.E. Fleischmann ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery Circulation 116 2007 1971 1996
49. N. Fallouh, and V. Chopra Statin withdrawal after major noncardiac surgery: risks, consequences, and preventative strategies J Hosp Med 7 2012 573 579
50. Y. Le Manach, P. Coriat, C.D. Collard, and B. Riedel Statin therapy within the perioperative period Anesthesiology 108 2008 1141 1146
51. K.I. Paraskevas, D.P. Mikhailidis, and F.J. Veith Optimal statin type and dosage for vascular patients J Vasc Surg 53 2011 837 844
52. K.I. Paraskevas, F.J. Veith, C.D. Liapis, and D.P. Mikhailidis Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update Curr Vasc Pharmacol 11 2013 112 120
53. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, and R. Belder Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504 (Pubitemid 38477774)
54. The Post Coronary Artery Bypass Graft Trial Investigators The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts N Engl J Med 336 1997 153 162
55. B.M. Biccard A peri-operative statin update for non-cardiac surgery. Part I: the effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (non-surgical) patients Anaesthesia 63 2008 52 64 (Pubitemid 350237622)
56. A. Kashani, C.O. Phillips, J.M. Foody, Y. Wang, S. Mangalmurti, and D.T. Ko Risks associated with statin therapy: a systematic overview of randomized clinical trials Circulation 114 2006 2788 2797 (Pubitemid 46018281)
57. B.M. Biccard, J.W. Sear, and P. Foëx Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease Anaesthesia 60 2005 1106 1114 (Pubitemid 41644901)
58. S.M. Grundy The issue of statin safety: where do we stand? Circulation 111 2005 3016 3019 (Pubitemid 40847775)
59. A. Turan, M.L. Mendoza, S. Gupta, J. You, A. Gottlieb, and W. Chu Consequences of succinylcholine administration to patients using statins Anesthesiology 115 2011 28 35